galactosamine has been researched along with dizocilpine maleate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agusti, A; Boix, J; Cauli, O; Felipo, V; Piedrafita, B; Rodrigo, R | 1 |
| Cabrera-Pastor, A; Carda, C; Carratalá, A; Cauli, O; Duszczyk, M; Felipo, V; Gimenez-Garzó, C; González-Usano, A; Hernández-Rabaza, V; Lazarewicz, JW; López-Larrubia, P; Malek, M; Miguel, A; Montoliu, C; Ruiz-Sauri, A; Torregrosa, I; Urios, A | 1 |
2 other study(ies) available for galactosamine and dizocilpine maleate
| Article | Year |
|---|---|
Acute liver failure-induced death of rats is delayed or prevented by blocking NMDA receptors in brain.
Topics: Ammonia; Animals; Brain; Disease Models, Animal; Disease Progression; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Galactosamine; Hepatic Encephalopathy; Hyperammonemia; Infusion Pumps, Implantable; Liver Failure, Acute; Male; Memantine; Microdialysis; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Severity of Illness Index; Time Factors | 2008 |
Blocking NMDA receptors delays death in rats with acute liver failure by dual protective mechanisms in kidney and brain.
Topics: Animals; Blood-Brain Barrier; Body Temperature; Brain; Brain Edema; Cerebrovascular Circulation; Disease Progression; Dizocilpine Maleate; Drug Evaluation, Preclinical; Excitatory Amino Acid Antagonists; Galactosamine; Glomerular Filtration Rate; Hepatic Encephalopathy; Hyperammonemia; Intracranial Hypertension; Inulin; Kidney; Lactates; Liver Failure; Liver Regeneration; Male; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Time Factors | 2014 |